AM
Amgen
AMGN · NASDAQ
$391.27 -0.46% (-$1.80)
1M -5.56%
Market Cap $211.2B
P/E Ratio 24.15x
Div. Yield 2.50%
ROE 89.32%
Bulios Fair Price
$530.46
35.6% upside
Trenutna cena
$391.27
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica AMGN trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
50 /100
Fair PEG 0.31x
P/S 5.54x
P/B 18.07x
Growth
53 /100
Stable Rev. growth 11.76%
FCF growth 2.67%
Book val. growth 33.23%
Profitability
100 /100
Strong Net margin 22.93%
Op. margin 33.18%
FCF margin 26.69%
Quality
78 /100
Excellent ROE 89.32%
ROA 9.14%
Asset turnover 0.40x
Debt
37 /100
Moderate Current ratio 1.37x
Int. coverage 4.86x
Net debt/EBITDA 2.62x
Stability
64 /100
Moderate Rev. volatility 5.98%
EPS volatility 65.02%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AMGN
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert A. Bradway
Employees
31,500
Headquarters
Thousand Oaks
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report